In its latest report, the Office for National Statistics (ONS) has updated the ethnic contrasts in deaths involving COVID-19 highlighting how patterns in rates of deaths involving COVID-19 between ethnic groups has changed over the course of the coronavirus pandemic. Their new report covers the period from January 10, 2022 to […]
Federal regulators announced Tuesday that GlaxoSmithKline’s COVID-19 drug should no longer be used because it’s likely ineffective against BA.2, the Omicron subvariant that now accounts for most new cases in the U.S., the Associated Press reports. The FDA announced that the antibody drug sotrovimab is no longer authorized to treat patients in U.S. […]
Federal regulators have announced that GlaxoSmithKline’s COVID-19 drug should no longer be used because it’s likely ineffective against BA.2, the Omicron subvariant that now accounts for most new cases in the United States, The Associated Press reports. The Food and Drug Administration announced that the antibody drug sotrovimab is no longer authorized to […]
The percentage of Omicron subvariant BA.2 cases is rising in Los Angeles County, a trend seen elsewhere nationwide as officials sound the alarm about Congress’ failure to provide critical funding for vaccinations, tests and anti-COVID drugs. Officials in L.A. County and nationally have warned about the risk to public health […]
HONG KONG — Durante la mayor parte de la pandemia de COVID-19, la vida en Hong Kong no dejó de ser un simulacro de normalidad. La ciudad mantuvo uno de los controles de fronteras más estrictos del mundo, e impuso una cuarentena de hasta tres semanas en hoteles para los […]
More than a third of COVID-19 cases in the U.S. are now caused by the Omicron subvariant BA.2. Although the proportion of BA.2 cases is increasing, overall infections are still declining from the record highs seen in January, according to Reuters. For the week ending March 19, BA.2 accounted for 35% […]
A key part of the immune system’s second-line defense – its T cells – are highly effective at recognizing and attacking the Omicron variant, a new study shows. Omicron’s mutations help it escape from antibodies, but researchers have speculated that other components of the immune response would still target Omicron. […]
In this open-label, nonrandomized clinical study, we assessed the immunogenicity and safety of a fourth dose of either BNT162b2 (Pfizer–BioNTech) or mRNA-1273 (Moderna) administered 4 months after the third dose in a series of three BNT162b2 doses (ClinicalTrials.gov numbers, NCT05231005. opens in new tab and NCT05230953. opens in new tab; the protocol is available with […]
The Omicron variant of SARS-CoV-2 is associated with significantly lower risks of hospitalisation and mortality compared with the Delta variant, according to the largest study to date to directly compare outcomes. Researchers in a multicentre UK team led by Imperial College London, the MRC Biostatistics Unit at the University of […]
The BA.2 Omicron lineage was estimated to be 23.1% of the coronavirus variants circulating in the United States as of March 12, the U.S. Centers for Disease Control and Prevention (CDC) said on Tuesday. Scientists are tracking a rise in cases caused by BA.2, which is spreading rapidly in parts […]
